News & Updates

In middle-aged adults, masked hypertension is associated with several markers of cardiovascular disease (CVD), which suggests that home blood pressure (BP) may be a better predictor of risk, even when the recordings are done with the same measurement device, according to a study.

The presence of cardiovascular disease (CVD) in peritoneal dialysis (PD) patients puts them at a significantly higher echocardiographic calcium score (ECS) than those without CVD, indicating much greater vascular calcification burden in the former, according to a Singapore study.

The addition of information on migraine with aura (MA) status to the cardiovascular disease (CVD) risk prediction algorithms results in a better model fit but falls short of substantially improving risk stratification among women, according to a study.

Young people with nonalcoholic fatty liver disease (NAFLD) are at increased risk of hypertension, especially women and those with more severe hepatic steatosis, as shown in a study.

The new standards for heart failure (HF) staging proposed in the 2022 American College of Cardiology (ACC)/American Heart Association (AHA)/Heart Failure Society of America (HFSA) clinical practice guideline has led to a considerable change among community-based individuals from stage A to B.

Combination treatment with pioglitazone plus a sodium-glucose co-transporter 2 (SGLT2) inhibitor helps reduce the risk of developing major adverse cardiovascular events (MACE) and heart failure in individuals with type 2 diabetes mellitus (T2DM) who have no history of cardiovascular disease (CV), as reported in a study.